Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Serina Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −2 vs. Q1 2025
- Shares held
- 413.1K
- +77.4K (+23.0%) vs. Q1 2025
- Total value
- $2.54M
- +$641.1K (+33.7%) vs. Q1 2025
- New holders
- 3
- 4 more added
- Sold out
- 5
- 5 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.73M |
| Q1 2026 | 25 | $2.86M |
| Q4 2025 | 22 | $821.8K |
| Q3 2025 | 25 | $2.48M |
| Q2 2025 | 23 | $2.54M |
| Q1 2025 | 25 | $1.90M |
| Q4 2024 | 25 | $1.60M |
| Q3 2024 | 25 | $2.01M |
| Q2 2024 | 21 | $1.96M |
| Q1 2024 | 13 | $1.48M |
| Q4 2023 | 35 | $1.91M |
| Q3 2023 | 30 | $3.29M |
| Q2 2023 | 32 | $4.24M |
| Q1 2023 | 34 | $3.15M |
| Q4 2022 | 31 | $2.66M |
| Q3 2022 | 32 | $2.67M |
| Q2 2022 | 33 | $2.75M |
| Q1 2022 | 33 | $4.09M |
| Q4 2021 | 38 | $5.28M |
| Q3 2021 | 32 | $4.46M |
| Q2 2021 | 35 | $7.48M |
| Q1 2021 | 38 | $8.21M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Serina Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 150,623 | $927.8K | 0.00% | +85,290+130.5% | Added |
| Broadwood Capital Inc | 85,219 | $524.9K | 0.03% | 00.0% | Unchanged |
| Warren Averett Asset Management, LLC | 67,492 | $415.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 28,884 | $177.9K | 0.00% | −322−1.1% | Reduced |
| HighTower Advisors, LLC | 17,911 | $110.3K | 0.00% | −3,522−16.4% | Reduced |
| Keel Point, LLC | 17,774 | $109.5K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 16,505 | $101.7K | 0.00% | −506−3.0% | Reduced |
| Susquehanna International Group, LLP | 13,237 | $81.5K | 0.00% | +13,237 | New |
| BlackRock, Inc. | 11,773 | $72.5K | 0.00% | +8,706+283.9% | Added |
| Toronto Dominion Bank | 3,554 | $21.9K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 38 | $234 | 0.00% | +38 | New |
| Bank of America Corp | 29 | $178 | 0.00% | +3+11.5% | Added |
| Piscataqua Savings Bank | 28 | $172 | 0.00% | 00.0% | Unchanged |
| Riggs Asset Managment Co. Inc. | 24 | $148 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 11 | $67 | 0.00% | +1+10.0% | Added |
| JPMorgan Chase & Co | 9 | $55 | 0.00% | −3−25.0% | Reduced |
| Albion Financial Group | 8 | $50 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8 | $49 | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 8 | $49 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2 | $12 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 2 | $12 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $6 | 0.00% | −746−99.9% | Reduced |
| Global Retirement Partners, LLC | 1 | $6 | 0.00% | +1 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,184−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,721−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −912−100.0% | Sold out |
| Ameriflex Group, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |